Literature DB >> 26154570

Risk Factors of Heterotopic Ossification Following Total Hip Arthroplasty in Patients With Ankylosing Spondylitis.

Jai Thilak1, Jiss Joseph Panakkal2, Tae-Young Kim3, Susan M Goodman4, Sang-Soo Lee3, Eduardo A Salvati4.   

Abstract

This study was to identify the risk factors of heterotopic ossification (HO) after total hip arthroplasty (THA) in ankylosing spondylitis. We analyzed 47 hips (24 patients) with ankylosing spondylitis that underwent primary THA. The incidence of HO was 14.9%. The risk factors were divided into modifiable and nonmodifiable factors. Female gender (P=0.008), preoperative ankylosed hip (P<0.001), occurrence of HO in previous surgery (P=0.036) were nonmodifiable risk factors which increased the prevalence of HO. Of the various modifiable risk factors, elevated preoperative ESR (P=0.007), elevated preoperative CRP (P=0.004) and prolonged duration of surgery (P=0.014) were associated with increased occurrence of HO. Perioperative medical intervention to reduce inflammation (ESR and CRP) may help to decrease HO.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ankylosing spondylitis; fused hip; heterotopic ossification; risk factor; total hip arthroplasty

Mesh:

Year:  2015        PMID: 26154570     DOI: 10.1016/j.arth.2015.06.013

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  10 in total

1.  [Functional outcomes of patients receiving total hip arthroplasty for ankylosing spondylitis].

Authors:  Wenrui Wu; Simin Luo; Ning Liu; Zhengang Zha
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-07-30

2.  The role of the adaptive immune system in burn-induced heterotopic ossification and mesenchymal cell osteogenic differentiation.

Authors:  Kavitha Ranganathan; Shailesh Agarwal; David Cholok; Shawn Loder; Jonathan Li; Hsiao Hsin Sung Hsieh; Stewart C Wang; Steven R Buchman; Benjamin Levi
Journal:  J Surg Res       Date:  2016-07-13       Impact factor: 2.192

3.  The Relationship between Plasma Pentraxin 3 and Serum Amyloid P Levels and Disease Activity in Ankylosing Spondylitis.

Authors:  Ali Erhan Özdemirel; Serdar Can Güven; İsmihan Sunar; Zühre Sari Sürmeli; Alper Doğanci; Hüseyin Tutkak; Ayşe Peyman Yalçin Sayin; Şebnem Ataman
Journal:  Int J Clin Pract       Date:  2022-03-24       Impact factor: 3.149

4.  Ankylosing spondylitis does not increase the risk of neurogenic heterotopic ossification in patients with a spinal cord injury: a retrospective cohort study.

Authors:  M Ohlmeier; P Karras; E M Suero; D Grasmücke; M Aach; R Meindl; T A Schildhauer; M Citak
Journal:  Spinal Cord       Date:  2016-10-18       Impact factor: 2.772

5.  Association of Genetic Variants in Pentraxin 3 Gene with Ankylosing Spondylitis.

Authors:  Xu Zhang; Wenyuan Ding
Journal:  Med Sci Monit       Date:  2016-08-18

6.  Mid-term results of bilateral synchronous total hip arthroplasty for bony ankylosis in patients with ankylosing spondylitis.

Authors:  Lei Han; Renfu Quan; Zhenle Pei; Guoping Cao; Yungen Hu; Jingjing Liu
Journal:  J Orthop Surg Res       Date:  2021-02-02       Impact factor: 2.359

7.  Fourth-Generation Ceramic-on-Ceramic THA in Patients with Ankylosing Spondylitis: A Minimum 10-Year Follow-Up.

Authors:  Liangliang Li; Jun Fu; Chi Xu; Ming Ni; Wei Chai; Libo Hao; Yonggang Zhou; Jiying Chen
Journal:  Orthop Surg       Date:  2022-04-18       Impact factor: 2.279

8.  Comparison of Outcomes of Total Hip Arthroplasty between Patients with Ankylosing Spondylitis and Avascular Necrosis of the Femoral Head.

Authors:  Sun-Ho Lee; Gun-Woo Lee; Young-Jun Seol; Kyung-Soon Park; Taek-Rim Yoon
Journal:  Clin Orthop Surg       Date:  2017-08-04

9.  Long-term Outcomes of Cemented Total Hip Arthroplasty in Patients with Ankylosing Spondylitis at a Minimum Follow-up of 10 Years.

Authors:  Soo Jae Yim; Yong Bok Park; Junyoung Kim; Sin Hyung Park
Journal:  Hip Pelvis       Date:  2018-09-04

10.  Effects of types and degrees of ankylosing spondylitis hip structural damages on post-total hip arthroplasty outcome measurements.

Authors:  Siliang Man; Xiaojian Ji; Liang Zhang; Zhengyuan Hu; Yanwei Lv; Yixin Zhou; Hui Song; Feng Huang
Journal:  Medicine (Baltimore)       Date:  2020-11-13       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.